• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Industrial Metals Market
    Industrial Metals News
    Industrial Metals Stocks
    • Industrial Metals Market
    • Industrial Metals News
    • Industrial Metals Stocks

    General Moly Closes $8.535-million Private Placement

    Charlotte McLeod
    Dec. 30, 2014 09:08AM PST
    Industrial Metals Investing

    General Moly Inc. (TSX:GMO,NYSEMKT:GMO) announced that it’s closed the private placement it announced on December 23, 2014 for gross proceeds of $8.535 million.

    General Moly Inc. (TSX:GMO,NYSEMKT:GMO) announced that it’s closed the private placement it announced on December 23, 2014 for gross proceeds of $8.535 million. The money will be used for general corporate purposes and for maintenance of the company’s Mt. Hope and Liberty projects.

    As quoted in the press release:

    The Company sold 85,350 units for $100 each. Each unit consists of one senior convertible note due 2019 (the ‘Notes’) with principal value of $100 and 100 five-year warrants to purchase the Company’s common stock at $1.00 per share. The Notes, which are senior to any General Moly debt obligations, mature on December 26, 2019, and have a 10% coupon rate payable quarterly. The Notes convert into common stock at a 20% discount to the greater of (i) the trailing 30-day volume weighted average price (‘VWAP’) at the date on which a Notice of Conversion is issued and (ii) the trailing 30-day VWAP as of December 22, 2014. Each Note will convert into a maximum of 100 shares per note, resulting in the issuance of 8,535,000 shares, or 9.3% of shares outstanding. General Moly’s executive management team and board of directors who participate in the offering will be restricted from converting at a price less than $0.32, the most recent closing price at the time that the Notes were issued.

    Bruce D. Hansen, CEO of General Moly, commented:

    The financing provides the Company with a bridge to a project financing for Mt. Hope while minimizing the dilution to our shareholders. The Private Placement included one $5 million block purchased by an investor with significant experience in the molybdenum sector, and General Moly’s executive management team and board of directors which invested over $2 million in aggregate. We believe that the investment made by our management team and board of directors provides a strong statement of support for the future prospects of General Moly.

    Click here to read the full General Moly Inc. (TSX:GMO,NYSEMKT:GMO) press release.

    general molyboard of directorsprivate placementnysemkt:gmotsx:gmo
    The Conversation (0)

    Go Deeper

    AI Powered
    NYSEAMERICAN:GMO

    General Moly Reports Q2 Loss, Expects Recovery on Price Increase

    General Moly Highlights Reinforced Financial Position with Third Quarter 2017 Results and Provides Molybdenum Market Overview

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES